MiR-124 Regulates Osteoblast Differentiation Through GSK-3β in Ankylosing Spondylitis
Overview
Pharmacology
Toxicology
Affiliations
Objective: Ankylosing spondylitis (AS) is a spastic and spinal joint disease with the characteristic of pathological ossification. Bioinformatics analysis demonstrated that there is a complementary binding site between microRNA-124 (miR-124) and the 3'-UTR of glycogen synthase kinase-3β (GSK-3β) mRNA. We aimed to investigate the role of miR-124 in regulating GSK-3β expression, Wnt/β-catenin pathway activity, and osteoblast differentiation of spinal ligament fibroblasts.
Patients And Methods: The ligament tissues of AS and the femoral neck fracture patients were collected. MiR-124 and GSK-3β mRNA expressions were detected by using quantitative Real-time PCR (qRT-PCR). GSK-3β and β-catenin protein expressions were detected by using Western blot. Ligament fibroblasts were isolated and induced to differentiate into osteoblasts. Alizarin red S staining (ARS) was used to identify osteoblast differentiation. Expressions of miR-124, GSK-3β, β-catenin, Osterix, and runt-related transcription factor 2 (RUNX2) were detected during differentiation. The cells were divided into two groups as agomiR-normal control (NC) transfection group and agomir miR-124 transfection group. Alkaline phosphatase (ALP) activity and Alizarin Red S staining were detected.
Results: MiR-124 and β-catenin expressions in the ligament of AS patients increased, while GSK-3β level reduced compared with control. MiR-124, β-catenin, Osterix, and RUNX2 expressions gradually elevated, whereas GSK-3β level gradually declined following increased osteoblasts differentiation. Antagomir miR-124 transfection significantly up-regulated the expression of GSK-3β in osteoblast differentiation, significantly decreased the expression of β-catenin, Osterix, and RUNX2, and significantly inhibited osteoblast differentiation.
Conclusions: MiR-124 decreased and GSK-3β elevated in AS ligament tissue. Down-regulation of miR-124 expression enhanced GSK-3β expression, weakened Wnt/β-catenin pathway activity, and inhibited the differentiation of ligament fibroblasts into osteoblasts.
The role of miRNAs as biomarkers in heterotopic ossification.
Xie C, Liu X, Li W, Yao Z, Men H, Li Z EFORT Open Rev. 2024; 9(12):1120-1133.
PMID: 39620561 PMC: 11619732. DOI: 10.1530/EOR-22-0100.
Zhao Y, Liu F, Pei Y, Lian F, Lin H J Cell Mol Med. 2024; 28(18):e70113.
PMID: 39320014 PMC: 11423343. DOI: 10.1111/jcmm.70113.
The MicroRNAs in the Pathophysiology of Osteoporosis.
Trojniak J, Sendera A, Banas-Zabczyk A, Kopanska M Int J Mol Sci. 2024; 25(11).
PMID: 38892426 PMC: 11172499. DOI: 10.3390/ijms25116240.
A potential function for MicroRNA-124 in normal and pathological bone conditions.
Kolipaka R, Magesh I, Ashok Bharathy M, Karthik S, Saranya I, Selvamurugan N Noncoding RNA Res. 2024; 9(3):687-694.
PMID: 38577015 PMC: 10990750. DOI: 10.1016/j.ncrna.2024.02.018.
Fibroblast Insights into the Pathogenesis of Ankylosing Spondylitis.
Liu Z, Cai M, Ke H, Deng H, Ye W, Wang T J Inflamm Res. 2023; 16:6301-6317.
PMID: 38149115 PMC: 10750494. DOI: 10.2147/JIR.S439604.